Feature | September 17, 2009 | Dina Blumwest, Bernadette M. Greenwood, BSRS, RT(R)(MR)

MRI Targets Prostate Lesions

MRI guides targeted localization of prostate lesions.

Fig. 1 Diffusion-weighted MRI image of the prostate gland.

Fig. 2 Trans-rectal interventional MRI biopsy.

Women worry about their own health, but are increasingly aware and educated about the health of their spouses, children and parents.
As September is Prostate Awareness Month, it is important for family members to understand the prevalence of prostate cancer, a disease that equated to an estimated 192,280 new cases and 27,360 deaths from prostate cancer in the United States in 2009, according to the American Cancer Society.
Dr. Jurgen Futterer, University of Nijmegen, says there are approximately 500,000 new prostate cancer cases worldwide, and in line with U.S.-statistics, about one in 35 will die from it.
A new technique for targeted localization of prostate lesions has been under development in Europe for over five years1 and is now available in the United States for select patients.
Similar to breast MR imaging and interventional capability, prostate cancer patients may be able to benefit from the high resolution of MR images and the ability to target, under MR-guidance, specific suspicious areas in the prostate2.
Currently, there are a number of patients that present with a persistent high or elevated PSA and or abnormal DRE, many of whom go on to multiple TRUS-guided biopsies with repeated negative results. In these situations, the patient and physician are without a diagnosis, and the patient is with a higher anxiety level.
Using MR images and biopsying under MRI-guidance minimizes the number of cores acquired by using true image guidance. The literature has shown that men with elevated or rising PSA or positive DRE with two, three, four or even more previous negative TRUS-guided biopsies may benefit from this approach3. So might men with suspicion of prostate cancer recurrence, detected through elevated PSAs following XRT, radical prostatectomy or other therapies.
MRI has a role in imaging and analysis of DCE prostate images as well as interventional planning, and is a way to further evaluate men with prostate cancer. Staging, node detection and evaluation of metastatic disease are areas where MRI has an evolving and important place4. Detection, localization and subsequent biopsy are possible in even outpatient environments (Fig. 1, Fig.2)5.
Urologists are very interested in solving the quandary of the patient with elevated or rising PSA and negative TRUS-guided biopsy. MRI can make a world of difference in these cases. As an emerging technique, it is easy enough to perform and is also well-tolerated by the patients who udergo it.

Bibliography
1. Beyersdorff D, Winkel A, Hamm B, Lenk S, Loening S, Taupitz M, MR Imaging-guided Prostate Biopsy with a Closed MR Unit at 1.5T: Initial Results, Radiology Vol. 234, No. 2, February, 2005:577-581
2. Aristotelis G. Anastasiadis, Matthias P. Lichy, Udo Nagele, Markus A. Kuczyk, Axel S. Merseburger, Joerg Hennenlotter, Stefan Corvin, Karl-Dietrich Sievert, Claus D. Claussen, Arnulf Stenzl, Heinz-Peter Schlemmer, MRI-Guided Biopsy of the Prostate Increases Diagnostic Performance in Men with Elevated or Increasing PSA Levels after Previous Negative TRUS Biopsies, European Urology, 50,2006: 738-749
3. Kirsten M. Pondman, Jurgen J. Fütterer, Bennie ten Haken, Leo J. Schultze Kool, J. Alfred Witjes, Thomas Hambrock, Katarzyna J. Macura, Jelle O. Barentsz, MR-Guided Biopsy of the Prostate: An Overview of Techniques and a Systematic Review, European Urology, Volume 54, Issue 3, September 2008, Pages 517-527
4. Hambrock T, Futterer J, Henkjan JH, Hulsbergen-vandeKaa C, vanBasten JP, vanOort I, Witjes JA, Barentsz JO, Thirty-Two-Channel Coil 3T Magnetic Resonance-Guided Biopsies of Prostate Tumor Suspicious Regions Identified on Multimodality 3T Magnetic Resonance Imaging: Technique and Feasibility, Investigative Radiology, Volume 43, Number 686 10, October 2008 , Pages 686-694
5. Feller JF, Greenwood BM, Jones W, Kaminsky DB, Walsh LP, European Society for Magnetic Resonance in Medicine and Biology, Use of trans-rectal interventional MRI (TRIM) for computer-aided prostate biopsy, Control Number 09-Cl-153-ESMRMB 2009

Related Content

Youth Football Changes Nerve Fibers in Brain

Statistically significant clusters (red-colored) showing group differences (Control vs. Football) in white matter strain along the primary (F1) and secondary (F2) fibers. While body of corpus callosum (BBC) showed relative shrinkage in Football group, the other clusters showed relative stretching of fibers. PCR: Posterior Corona Radiata, PLIC: Posterior Limb of Internal Capsule, SCR: Superior Corona Radiata, SLF: Superior Longitudinal Fasciculus, SCC: Splenium of Corpus Callosum. Image courtesy of Kim et al.

News | Neuro Imaging | December 07, 2018
Magnetic resonance imaging (MRI) scans show repetitive blows to the head result in brain changes among youth football...
Siemens Healthineers Debuts Magnetom Altea 1.5T MRI Scanner
Technology | Magnetic Resonance Imaging (MRI) | December 06, 2018
During the 104th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), Nov. 25-30...
GE Healthcare Unveils New Applications and Smart Devices Built on Edison Platform
Technology | Artificial Intelligence | December 05, 2018
GE Healthcare recently announced new applications and smart devices built on Edison – a platform that helps accelerate...
Snoring Poses Greater Cardiac Risk to Women
News | Women's Health | November 29, 2018
Obstructive sleep apnea (OSA) and snoring may lead to earlier impairment of cardiac function in women than in men,...
Vital Showcases Enterprise Imaging Advances at RSNA 2018

Global Illumination from Vital Images

News | Enterprise Imaging | November 28, 2018
Vital, a Canon Group company, will highlight the latest additions to its enterprise imaging portfolio at the 2018...
Artificial Intelligence May Help Reduce Gadolinium Dose in MRI

Example of full-dose, 10 percent low-dose and algorithm-enhanced low-dose. Image courtesy of Enhao Gong, Ph.D.

News | Contrast Media | November 27, 2018
Researchers are using artificial intelligence (AI) to reduce the dose of a contrast agent that may be left behind in...
Arterys Demonstrates AI Cloud-Based Medical Image Analysis Solutions at RSNA 2018
News | Computer-Aided Detection Software | November 26, 2018
Medical imaging software company Arterys will demonstrate its wide-ranging suite of artificial intelligence (AI)-...
HeartVista Announces One Click Autonomous MRI Solution
News | Magnetic Resonance Imaging (MRI) | November 25, 2018
HeartVista announced its artificial intelligence (AI)-driven, One-Click Autonomous MRI acquisition software for cardiac...
Siemens Healthineers Showcases syngo Virtual Cockpit for More Flexible Workforce Management
News | Teleradiology | November 25, 2018
During the 104th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), Nov. 25-30...
Canon Medical Receives FDA Clearance for Vantage Orian 1.5T MRI
Technology | Magnetic Resonance Imaging (MRI) | November 15, 2018
Canon Medical Systems USA Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) on its new...